Literature DB >> 18759822

Risk of cardiovascular and cerebrovascular events in primary biliary cirrhosis: a population-based cohort study.

Masoud Solaymani-Dodaran1, Guruprasad P Aithal, Tim Card, Joe West.   

Abstract

BACKGROUND: Hyperlipidemia is a common finding among patients with primary biliary cirrhosis (PBC). However, whether this results in higher rates of cardiovascular and cerebrovascular events in PBC patients compared with the general population is unclear.
METHODS: We compared the risk of developing myocardial infarction (MI), stroke, and transient ischemic attack (TIA) in a cohort of people with PBC with a general population control cohort matched on age, sex, and general practice (GP). Subjects were selected from the General Practice Research Database (GPRD). Hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated using Cox regression.
RESULTS: Nine hundred thirty PBC patients (88% female) were compared with 9,202 controls. During a total of about 43,700 person-years of follow-up, 244 MIs, 591 strokes, and 221 TIAs were identified. Incidence rates per 1,000 person-years for MI, stroke, and TIA during the study period were 5.9 (3.9-9.0), 13.8 (10.5-18.2), and 3.5 (2.0-6.0) for PBC cohorts and 5.6 (4.9-6.4), 14.0 (12.9-15.2), and 5.3 (4.6-6.0) for control cohorts, respectively. HRs in PBC cohort compared with the control cohort were for any vascular event 0.99 (95% CI 0.77-1.27) MI 1.04 (95% CI 0.67-1.62), stroke 0.98 (95% CI 0.73-1.31), and TIA 0.66 (95% CI 0.38-1.16). Adjustment for confounders did not change the results substantially.
CONCLUSIONS: PBC was not associated with an increased risk of MI, stroke, or TIA in this cohort. Therefore, strategies for the prevention of vascular events in PBC patients should be similar to those in the general population.

Entities:  

Mesh:

Year:  2008        PMID: 18759822     DOI: 10.1111/j.1572-0241.2008.02092.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  12 in total

1.  Assessment of metabolic syndrome in patients with primary biliary cirrhosis.

Authors:  Tamara Alempijevic; Aleksandra Sokic-Milutinovic; Aleksandra Pavlovic Markovic; Rada Jesic-Vukicevic; Biljana Milicic; Djuro Macut; Dragan Popovic; Dragan Tomic
Journal:  Wien Klin Wochenschr       Date:  2012-04-25       Impact factor: 1.704

Review 2.  Abnormalities of Lipoprotein Levels in Liver Cirrhosis: Clinical Relevance.

Authors:  Graziella Privitera; Luisa Spadaro; Simona Marchisello; Giuseppe Fede; Francesco Purrello
Journal:  Dig Dis Sci       Date:  2017-11-25       Impact factor: 3.199

3.  The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines.

Authors:  Gideon M Hirschfield; Jessica K Dyson; Graeme J M Alexander; Michael H Chapman; Jane Collier; Stefan Hübscher; Imran Patanwala; Stephen P Pereira; Collette Thain; Douglas Thorburn; Dina Tiniakos; Martine Walmsley; George Webster; David E J Jones
Journal:  Gut       Date:  2018-03-28       Impact factor: 23.059

4.  Association Between Cirrhosis and Stroke in a Nationally Representative Cohort.

Authors:  Neal S Parikh; Babak B Navi; Yecheskel Schneider; Arun Jesudian; Hooman Kamel
Journal:  JAMA Neurol       Date:  2017-08-01       Impact factor: 18.302

Review 5.  Statins Show Promise Against Progression of Liver Disease.

Authors:  Prashanth Francis; Lisa M Forman
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-12-20

6.  Fenofibrate in primary biliary cirrhosis: a pilot study.

Authors:  E N Liberopoulos; M Florentin; M S Elisaf; D P Mikhailidis; E Tsianos
Journal:  Open Cardiovasc Med J       Date:  2010-04-28

7.  Use of statins in patients with liver disease.

Authors:  Sweta Tandra; Raj Vuppalanchi
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-08

8.  Risk of Cardiovascular Events in Patients with Primary Biliary Cholangitis - Systematic Review.

Authors:  Duminda Suraweera; Christina Fanous; Melissa Jimenez; Myron J Tong; Sammy Saab
Journal:  J Clin Transl Hepatol       Date:  2018-02-14

9.  The extrahepatic events of Asian patients with primary biliary cholangitis: A 30-year cohort study.

Authors:  Cheng-Yu Lin; Ya-Ting Cheng; Ming-Ling Chang; Rong-Nan Chien
Journal:  Sci Rep       Date:  2019-05-20       Impact factor: 4.379

10.  Prevalence of pre-transplant electrocardiographic abnormalities and post-transplant cardiac events in patients with liver cirrhosis.

Authors:  Axel Josefsson; Michael Fu; Einar Björnsson; Evangelos Kalaitzakis
Journal:  BMC Gastroenterol       Date:  2014-04-05       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.